Quality indicators (QIs) are crucial for evaluating health care delivery, including effectiveness, safety, and patient-centered outcomes.
In contrast to other fields, the definition and implementation of QIs for renal cell carcinoma (RCC) present distinct challenges and remain unmet needs.
We summarized the available data on QIs for RCC, focusing on their characterization throughout the care pathway and the potential areas for further development.
